These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 11258893
1. Interaction of the N-terminal domain of apolipoprotein E4 with heparin. Dong J, Peters-Libeu CA, Weisgraber KH, Segelke BW, Rupp B, Capila I, Hernáiz MJ, LeBrun LA, Linhardt RJ. Biochemistry; 2001 Mar 06; 40(9):2826-34. PubMed ID: 11258893 [Abstract] [Full Text] [Related]
2. Two-step mechanism of binding of apolipoprotein E to heparin: implications for the kinetics of apolipoprotein E-heparan sulfate proteoglycan complex formation on cell surfaces. Futamura M, Dhanasekaran P, Handa T, Phillips MC, Lund-Katz S, Saito H. J Biol Chem; 2005 Feb 18; 280(7):5414-22. PubMed ID: 15583000 [Abstract] [Full Text] [Related]
6. New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E. Libeu CP, Lund-Katz S, Phillips MC, Wehrli S, Hernáiz MJ, Capila I, Linhardt RJ, Raffaï RL, Newhouse YM, Zhou F, Weisgraber KH. J Biol Chem; 2001 Oct 19; 276(42):39138-44. PubMed ID: 11500500 [Abstract] [Full Text] [Related]
7. Characterization of the heparin binding sites in human apolipoprotein E. Saito H, Dhanasekaran P, Nguyen D, Baldwin F, Weisgraber KH, Wehrli S, Phillips MC, Lund-Katz S. J Biol Chem; 2003 Apr 25; 278(17):14782-7. PubMed ID: 12588864 [Abstract] [Full Text] [Related]
8. Enzymatic preparation of heparin oligosaccharides containing antithrombin III binding sites. Toida T, Hileman RE, Smith AE, Vlahova PI, Linhardt RJ. J Biol Chem; 1996 Dec 13; 271(50):32040-7. PubMed ID: 8943254 [Abstract] [Full Text] [Related]
9. Kinetics of apolipoprotein E isoforms-binding to the major glycosaminoglycans of the extracellular matrix. Shuvaev VV, Laffont I, Siest G. FEBS Lett; 1999 Oct 15; 459(3):353-7. PubMed ID: 10526164 [Abstract] [Full Text] [Related]
12. Structural variation in human apolipoprotein E3 and E4: secondary structure, tertiary structure, and size distribution. Chou CY, Lin YL, Huang YC, Sheu SY, Lin TH, Tsay HJ, Chang GG, Shiao MS. Biophys J; 2005 Jan 15; 88(1):455-66. PubMed ID: 15475580 [Abstract] [Full Text] [Related]
13. Examination of lipid-bound conformation of apolipoprotein E4 by pyrene excimer fluorescence. Drury J, Narayanaswami V. J Biol Chem; 2005 Apr 15; 280(15):14605-10. PubMed ID: 15708851 [Abstract] [Full Text] [Related]
14. Interaction of heparin with annexin V. Capila I, VanderNoot VA, Mealy TR, Seaton BA, Linhardt RJ. FEBS Lett; 1999 Mar 12; 446(2-3):327-30. PubMed ID: 10100868 [Abstract] [Full Text] [Related]
15. Preparation and structural characterization of large heparin-derived oligosaccharides. Pervin A, Gallo C, Jandik KA, Han XJ, Linhardt RJ. Glycobiology; 1995 Feb 12; 5(1):83-95. PubMed ID: 7772871 [Abstract] [Full Text] [Related]
16. Lipid binding ability of human apolipoprotein E N-terminal domain isoforms: correlation with protein stability? Weers PM, Narayanaswami V, Choy N, Luty R, Hicks L, Kay CM, Ryan RO. Biophys Chem; 2003 Feb 12; 100(1-3):481-92. PubMed ID: 12646385 [Abstract] [Full Text] [Related]
17. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides. Fromm JR, Hileman RE, Weiler JM, Linhardt RJ. Arch Biochem Biophys; 1997 Oct 15; 346(2):252-62. PubMed ID: 9343372 [Abstract] [Full Text] [Related]
18. Comparison of the stabilities and unfolding pathways of human apolipoprotein E isoforms by differential scanning calorimetry and circular dichroism. Acharya P, Segall ML, Zaiou M, Morrow J, Weisgraber KH, Phillips MC, Lund-Katz S, Snow J. Biochim Biophys Acta; 2002 Sep 05; 1584(1):9-19. PubMed ID: 12213488 [Abstract] [Full Text] [Related]
19. Effect of carboxyl-terminal truncation on structure and lipid interaction of human apolipoprotein E4. Tanaka M, Vedhachalam C, Sakamoto T, Dhanasekaran P, Phillips MC, Lund-Katz S, Saito H. Biochemistry; 2006 Apr 04; 45(13):4240-7. PubMed ID: 16566598 [Abstract] [Full Text] [Related]
20. Full-length apolipoprotein E protects against the neurotoxicity of an apoE-related peptide. Crutcher KA, Lilley HN, Anthony SR, Zhou W, Narayanaswami V. Brain Res; 2010 Jan 08; 1306():106-15. PubMed ID: 19836363 [Abstract] [Full Text] [Related] Page: [Next] [New Search]